期刊文献+

鹿骨瓜子肽胶囊促进骨细胞增殖及其毒理稳定性研究 被引量:2

Effect of Deer bone and Seeds peptide capsule on osteoblasts proliferation,toxicology and stability
原文传递
导出
摘要 目的:综合评价抗骨质疏松产品——鹿骨瓜子肽胶囊。方法:抗骨质疏松实验采用新生SD大鼠成骨细胞体外培养法,测定MTT,ALK和矿化骨结节;安全性毒理学评价采用急性毒性、微核实验、精子畸变,Ames实验以及30d喂养实验;进行稳定性加速实验,观察感官、微生物、重金属、崩解时限、水分、灰分以及鹿骨瓜子肽含量。结果:鹿骨瓜子肽对新生SD大鼠成骨细胞有明显增殖作用,ALK活性增强、矿化骨结节数量增多;鹿骨瓜子肽胶囊无毒、无诱变、无致突变;每100g含多肽≥8.0g,保质期为24个月,微生物、重金属、崩解时限、水分、灰分均符合国家标准和企业质量标准。结论:鹿骨瓜子肽胶囊是一种安全、有效,质量可控,增加骨密度、防治中老年人骨质疏松症的健康产品。 Objective:To evaluate the anti-osteoporosis effect of Deer bone and Seeds peptide (DBS) capsule.Methods:In vitro anti-osteoporosis effect was evaluated by MTT reduction assay,and by detection of alkaline phosphatase (ALK) and mineralized nodes in osteoblasts from SD rats.The accelerated stability tests included determinations of appearance,microorganisms,heavy metals,disintegration time,and the contents of water,ash and DBS.Results:DBS capsule enhanced cell proliferation,ALK activity and the number of mineralized nodes in rat osteoblasts.Toxicological assessments showed that DBS capsule was completely not poisonous and had no potential of mutagenesis.The content of peptide was ≥8.0 g per 100 g in the capsule.The capsules' shelf life reached 24 months.All the indexes were conformed to match GB and the corporation quality standards,including those in microorganisms,heavy metals,disintegration,moisture barrier and ash.Conclusion:DBS capsule is an effective and safe product with controllable quality for enhancing bone mineral density,prevention and control of osteoporosis in middle-aged and senile people.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第7期617-621,637,共6页 Chinese Journal of New Drugs
基金 广东省科技厅计划项目(2008B030301015 2009B0303801339)
关键词 鹿骨瓜子肽胶囊 骨质疏松 骨细胞增殖 毒理 稳定性 Deer bone and Seeds peptide (DBS) capsule osteoporosis osteoblasts proliferation toxicology stability
  • 相关文献

参考文献19

  • 1SINHA V, SINGH A, KUMAR RV,et al. Oral colon-specific drug delivery of protein and peptide drugs [ J ]. Crit Rev Ther Drug Carrier Syst, 2007, 24( 1 ) :63 -92.
  • 2CHOURASIA MK, JA1N SK. Pharmaceutical approaches to colon targeted drug delivery systems [ J ]. J Pharm Pharm Sci, 2003, 6(1): 33-66.
  • 3李延平,刘义,吴科锋,邓亦峰,艾春媚,李彩虹,崔燎.骨元肽结肠溶胶囊对去卵巢大鼠骨质疏松症的防治作用[J].中国药理学通报,2008,24(3):340-343. 被引量:7
  • 4李延平,邓亦峰,吴科锋,刘义,崔燎.骨元肽分子量分布及大鼠在体结肠吸收的实验研究[J].中国骨质疏松杂志,2008,14(2):95-97. 被引量:4
  • 5中华人民共和国卫生部卫生法制与监督司主编.保健食品检验与评价技术规范[M].北京:中华人民共和国卫生部,2003:177-242.
  • 6广东洪江麒麟生物实业有限公司.麒琳鹿骨瓜子肽胶囊企业标准[S].Q/ZQL01-2006.
  • 7中华人民共和国卫生部.食品卫生微生物学菌落总数测定[S].北京:中国国家标准管理委员会,GB/T4789.2-2003.
  • 8中华人民共和国卫生部.食品卫生微生物学大肠菌群测定[S].北京:中国国家标准管理委员会,GB/T4789.3-2003.
  • 9国家标准管理委员会.食品卫生微生物学沙门氏菌检验[s].GB/T4789.4-2003.
  • 10国家标准管理委员会.食品卫生微生物学志贺氏菌检验[S].GB/T4789.5-2003.

二级参考文献15

  • 1刘钰瑜,崔燎,吴铁,姚卫民,艾春媚.大黄素对体外培养新生大鼠颅骨成骨细胞的影响[J].中国药理学通报,2005,21(2):235-240. 被引量:23
  • 2刘钰瑜,姚卫民,艾春媚,许碧连,邹丽宜,吴铁,崔燎.大黄素对大鼠体外颅骨成骨细胞的影响[J].中国药理学通报,2005,21(12):1473-1477. 被引量:10
  • 3段冷昕,马吉胜,翁梁,王丽娟,陈声武,刘永强,王本祥,周秋丽.鹿茸总多肽对维A酸致骨质疏松大鼠的防治作用[J].中国药学杂志,2007,42(4):264-267. 被引量:32
  • 4Sinha V, Singh A, Kumar RV, et al. Oral colon-specific drug delivery of protein and peptide drugs. Crit Rev Ther Drug Carrier Syst, 2007,24( 1 ) : 63-92.
  • 5Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci, 2003,6( 1 ):33-66.
  • 6Lu B.. Pharmaceutical Experiment (药剂学实验)..Beijing: People's Medical Publishing House,, 1994....
  • 7Sun Xiwei, Zhou Lingfang, Sun Jie. Colonic drug targeting and an updated review. Chin JMAP,2002,19(3) : 196-198.
  • 8Shareef MA, Khar RK, Ahuja A, et al. Colonic drug delivery: an updated review. AAPS Pharm Sci,2003,5(2):E17.
  • 9Haupt S, Rubinstein A. The colon as a possible target for orally administered peptide and protein drugs. Crit Rev Ther Drug Carrier Syst,2002,19(6) :499-551.
  • 10Martin R B. Fatigue microdamage as an essential element of bone mechanics and biology[J]. Calcif Tissue Int,2003,73 (2) :101 - 7.

共引文献28

同被引文献5

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部